NEREUS PHARMACEUTICALS
Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent for the treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.
NEREUS PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical
Founded:
1998-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.nereuspharm.com
Total Employee:
11+
Status:
Active
Contact:
19999999999
Email Addresses:
[email protected]
Total Funding:
139.8 M USD
Technology used in webpage:
SPF Microsoft Exchange Online GoDaddy Network Solutions DNS
Similar Organizations
Capulus Therapeutics
Capulus Therapeutics engages in drug discovery and development with a predictive AI guided approach to target the root cause of diseases.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Multiple Myeloma Research Foundation
The MMRF relentlessly pursues innovative means that accelerate the development of next-generation multiple myeloma treatments to extend
NAEJA-RGM Pharmaceuticals
NAEJA-RGM Pharmaceuticals engages in proprietary drug discovery work and is a player in the field of infectious disease research.
Current Advisors List
Current Employees Featured
Founder
Investors List
Pacific Venture Group
Pacific Venture Group investment in Series E - Nereus Pharmaceuticals
Forward Ventures
Forward Ventures investment in Series E - Nereus Pharmaceuticals
Alta Partners
Alta Partners investment in Series E - Nereus Pharmaceuticals
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series E - Nereus Pharmaceuticals
Astellas Venture Management
Astellas Venture Management investment in Series E - Nereus Pharmaceuticals
Roche Venture Fund
Roche Venture Fund investment in Series E - Nereus Pharmaceuticals
Advent International
Advent International investment in Series E - Nereus Pharmaceuticals
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series D - Nereus Pharmaceuticals
Roche Venture Fund
Roche Venture Fund investment in Series D - Nereus Pharmaceuticals
Astellas Venture Management
Astellas Venture Management investment in Series D - Nereus Pharmaceuticals
Official Site Inspections
http://www.nereuspharm.com
- Host name: 98.220.74.97.host.secureserver.net
- IP address: 97.74.220.98
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
